[EN] BIOMARKERS FOR DETERMINING SUSCEPTIBILITY TO OXOPIPERAZINE DERIVATIVES AND METHODS OF USING SAME<br/>[FR] BIOMARQUEURS POUR DÉTERMINER LA SENSIBILITÉ À DES DÉRIVÉS D'OXOPIPÉRAZINE ET LEURS MÉTHODES D'UTILISATION
申请人:INTHERA BIOSCIENCE AG
公开号:WO2021144302A1
公开(公告)日:2021-07-22
The disclosure provides methods of treating a subject with cancer comprising determining the expression or activity of one or more genes in the p53 and/or Rb pathways, and administering a CBP/p300 modulating compound.